Tazarotene Aerosol, Foam
Product Images NDC 68308-685

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tazarotene (NDC 68308-685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tazarotene 01)

Chemical structure of tazarotene, the active ingredient, showing its molecular arrangement including a thiochromene moiety connected to a pyridine ring and an ethyl ester group.*

FDA Label Image

Figure A (Tazarotene 02)

An instructional diagram showing a hand holding and pressing the top of a foam aerosol can, with the other hand positioned above the nozzle as if to catch or apply foam. This image likely demonstrates the proper way to dispense foam from a topical aerosol product.*

FDA Label Image

Figure B (Tazarotene 03)

An instructional image showing a person dispensing tazarotene 1 mg/g topical foam aerosol from a white canister onto the fingers of one hand, demonstrating the application process of the medication.*

FDA Label Image

Figure C (Tazarotene 04)

An instructional image showing a person dispensing tazarotene foam from an aerosol can onto their palm, demonstrating the topical application method for this prescription drug.*

FDA Label Image

Figure D (Tazarotene 05)

The image shows two black-and-white photos demonstrating the use of tazarotene 1 mg/g topical aerosol foam. The left photo displays foam dispensed into a person's palm from an aerosol can. The right photo shows a person applying the foam to their facial skin using their fingertips.*

FDA Label Image

Figure E (Tazarotene 06)

An illustration showing a person's hands under running water, demonstrating hand washing. The image is likely instructional, showing the proper method to rinse or wash hands.*

FDA Label Image

Principal Display Panel (50 g Can Carton)

Tazarotene Foam, 0.1% (1 mg/g) topical aerosol foam in a 50-gram recyclable aluminum container labeled by Mayne Pharma Inc. The packaging includes usage instructions, storage conditions, flammability warnings, and ingredient details. The product is distributed by Mayne Pharma in Greenville, NC, and is made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.